Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06888453Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by Al-Mustansiriyah University. Primary endpoint: Gingival Index at 7 days. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06888453.